BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 17452738)

  • 21. Dietary quality index is negatively associated with serum advanced glycation end products in healthy adults.
    Foroumandi E; Alizadeh M; Kheirouri S
    Clin Nutr ESPEN; 2020 Apr; 36():111-115. PubMed ID: 32220353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.
    Vlassara H; Cai W; Goodman S; Pyzik R; Yong A; Chen X; Zhu L; Neade T; Beeri M; Silverman JM; Ferrucci L; Tansman L; Striker GE; Uribarri J
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4483-91. PubMed ID: 19820033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients.
    Sotomayor CG; Gomes-Neto AW; van Londen M; Gans ROB; Nolte IM; Berger SP; Navis GJ; Rodrigo R; Leuvenink HGD; Schalkwijk CG; Bakker SJL
    Clin J Am Soc Nephrol; 2019 Oct; 14(10):1512-1520. PubMed ID: 31530552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease.
    Vlassara H; Uribarri J; Cai W; Goodman S; Pyzik R; Post J; Grosjean F; Woodward M; Striker GE
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):934-42. PubMed ID: 22461535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men.
    Macías-Cervantes MH; Rodríguez-Soto JM; Uribarri J; Díaz-Cisneros FJ; Cai W; Garay-Sevilla ME
    Nutrition; 2015 Mar; 31(3):446-51. PubMed ID: 25701333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients.
    Schulman CI; Uribarri J; Cai W; Manning R; Landy DC; Gallardo M; Castillo A; Namias N; Striker GE; Livingstone A; Vlassara H
    Clin Chem Lab Med; 2014 Jan; 52(1):103-8. PubMed ID: 23612541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescent serum and urinary advanced glycoxidation end-products in non- diabetic subjects.
    Maza MP; Bravo A; Leiva L; Gattás V; Petermann M; Garrido F; Bunout D; Hirsch S; Barrera G; Fernández M
    Biol Res; 2007; 40(2):203-12. PubMed ID: 18064357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults.
    Semba RD; Najjar SS; Sun K; Lakatta EG; Ferrucci L
    Am J Hypertens; 2009 Jan; 22(1):74-9. PubMed ID: 19023277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes.
    Di Pino A; Currenti W; Urbano F; Scicali R; Piro S; Purrello F; Rabuazzo AM
    Nutr Metab Cardiovasc Dis; 2017 Nov; 27(11):978-984. PubMed ID: 28958695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy.
    Vlassara H; Cai W; Crandall J; Goldberg T; Oberstein R; Dardaine V; Peppa M; Rayfield EJ
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15596-601. PubMed ID: 12429856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of serum and dietary advanced glycation endproducts in relation to cardiac function and structure: The Hoorn Study.
    Kremers SHM; Remmelzwaal S; Schalkwijk CG; Elders PJM; Stehouwer CDA; van Ballegooijen AJ; Beulens JWJ
    Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3167-3175. PubMed ID: 34518083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study.
    Martens RJH; Broers NJH; Canaud B; Christiaans MHL; Cornelis T; Gauly A; Hermans MMH; Konings CJAM; van der Sande FM; Scheijen JLJM; Stifft F; Wirtz JJJM; Kooman JP; Schalkwijk CG
    PLoS One; 2019; 14(8):e0221058. PubMed ID: 31408493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced glycation endproducts in food and their effects on health.
    Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
    Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.
    Meertens JH; Nienhuis HL; Lefrandt JD; Schalkwijk CG; Nyyssönen K; Ligtenberg JJ; Smit AJ; Zijlstra JG; Mulder DJ
    PLoS One; 2016; 11(8):e0160893. PubMed ID: 27529340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.
    Cai W; Uribarri J; Zhu L; Chen X; Swamy S; Zhao Z; Grosjean F; Simonaro C; Kuchel GA; Schnaider-Beeri M; Woodward M; Striker GE; Vlassara H
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4940-5. PubMed ID: 24567379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Habitual intake of advanced glycation endproducts is not associated with worse insulin sensitivity, worse beta cell function, or presence of prediabetes or type 2 diabetes: The Maastricht Study.
    Linkens AMA; Eussen SJMP; Houben AJHM; Mari A; Dagnelie PC; Stehouwer CDA; Schalkwijk CG
    Clin Nutr; 2023 Aug; 42(8):1491-1500. PubMed ID: 37302878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.
    Semba RD; Ferrucci L; Sun K; Beck J; Dalal M; Varadhan R; Walston J; Guralnik JM; Fried LP
    Aging Clin Exp Res; 2009 Apr; 21(2):182-90. PubMed ID: 19448391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes.
    Gradinaru D; Borsa C; Ionescu C; Margina D
    J Proteomics; 2013 Oct; 92():313-22. PubMed ID: 23587667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients.
    Chao PC; Huang CN; Hsu CC; Yin MC; Guo YR
    Eur J Nutr; 2010 Oct; 49(7):429-34. PubMed ID: 20229096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men.
    Sjögren P; Basta G; de Caterina R; Rosell M; Basu S; Silveira A; de Faire U; Vessby B; Hamsten A; Hellenius ML; Fisher RM
    Atherosclerosis; 2007 Dec; 195(2):e168-75. PubMed ID: 17655851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.